A pharmaceutical company wanted to understand if potential functionalities of a digital therapy met user needs.
A pharmaceutical company sought exploratory research to explore whether potential functionalities of a digital therapy would be desired by end users. We were tasked with understanding how these new functions would be accepted by end users as well as identifying additional needs or desires of user groups.
We conducted remote exploratory interviews with patients and healthcare providers, using their journeys from diagnosis to treatment to guide the development of potential interfaces. Patient recruiting included adults and minor participants (aged 5-17) with amblyopia, a type of visual impairment; some also had additional diagnoses, such as epilepsy or cerebral palsy, which impacted their mobility and cognitive abilities.
Our research indicated that the concept for this therapy was well received by nearly all HCP and patient participants. Our data from this study informed the development of a user interface design for this digital therapy and offered additional insights on the needs and preferences of end users.